Skip to main content

Hoge Stephen's Form 4 filing

Moderna, Inc. (MRNA) · filed Mar 2, 2023

Accession no.
0001127602-23-008449
Filed
Mar 2, 2023
Trade date
Feb 28-Mar 1, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market sales total $148.0K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hoge StephenCIK 0001760669Officer (President)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 28, 2023Common StockMOption exerciseAcquired+2,410$0.00$01,630,103Direct
Mar 1, 2023Common StockSSaleDisposed−1,072$138.03−$147,968.161,629,031Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 28, 2023Common StockMOption exerciseDisposed−2,410$0.00$09,643Direct
Feb 28, 2023Common StockAGrant or awardAcquired+37,217$0.00$037,217Direct
Feb 28, 2023Common StockAGrant or awardAcquired+9,768$0.00$09,768Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)